PHIO PHARMACEUTICALS CORP. Convertible Preferred Stock, Shares Issued upon Conversion
PHIO PHARMACEUTICALS CORP. (PHIO) had Convertible Preferred Stock, Shares Issued upon Conversion of 1.11 thousand shares as of 2016-12-21, per its 10-K filed 2017-03-30.
Discontinued › Notes › Stockholders' Equity Note › Class of Stock Disclosures
us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion · last filed 2017-03-30
- 2016-12-21: Convertible Preferred Stock, Shares Issued upon Conversion 1.11K shares.
| Period end | Convertible Preferred Stock, Shares Issued upon Conversion |
|---|---|
| 2016-12-21 | 1.11K shares 10-K · filed 2017-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |